Monitoring and treatment of inactive chronic hepatitis B: is it cost-effective?

Hepatology. 2014 Jul;60(1):19-21. doi: 10.1002/hep.27062. Epub 2014 May 27.

Authors

Zobair Younossi¹, Linda Henry

Affiliation

¹ Department of Medicine, Inova Fairfax Hospital, Falls Church, VA; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA.

PMID: 24504789
DOI: 10.1002/hep.27062

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antiviral Agents / therapeutic use*
Carcinoma, Hepatocellular*
Hepatitis B, Chronic*
Humans
Liver Neoplasms*
Monitoring, Immunologic / economics*
Virus Inactivation*

Substances

Antiviral Agents